The demand for needle-free weight loss medications has exploded in the UK. As injections like Wegovy and Mounjaro become mainstream, many people are now asking a very specific question:

Is there a weight loss pill that actually works and which one is better?

Two names dominate this conversation:

Wegovy pill form (oral semaglutide)
Orforglipron pill form (Eli Lilly’s oral GLP-1)

Both target the same biological pathway as injectable GLP-1 medications, but they differ significantly in scientific evidence, convenience, availability, and long-term potential.

This article breaks down the data, compares the pills side by side, and gives a clear, honest verdict based on current science with a UK-specific perspective.

Table of Contents

What Are Wegovy Pill and Orforglipron Pill?

Wegovy Pill form (Oral Semaglutide)

The Wegovy pill contains semaglutide, a GLP-1 receptor agonist already widely used in injectable form. The pill version uses a much higher dose to compensate for reduced absorption in the stomach.

It is:

Taken once daily
Requires strict fasting rules
Approved in the United States (December 2025)
Under MHRA review in the UK (not yet authorised as of 2026)

Orforglipron Pill form

Orforglipron is a next-generation oral GLP-1 that is not a peptide. It was designed from the start to work as a tablet, not adapted from an injection.

It is:

Taken once daily
Does not require fasting or water restrictions (based on development data)
Still in clinical development
Not yet approved but promising

How Do These Pills Work?

Both medications activate the GLP-1 receptor, which:

Reduces appetite
Slows gastric emptying
Improves insulin sensitivity
Increases feelings of fullness

The difference lies in drug design:

Wegovy pill uses a peptide hormone
Orforglipron uses a small-molecule compound

This difference impacts dosing rules, tolerability, and future scalability.

Weight Loss Results: Which Is More Effective?

Wegovy Pill Weight Loss Data

In Phase 3 obesity trials (OASIS programme), oral semaglutide produced:

~13–14% average weight loss
Measured at 64 weeks
Significantly better results than placebo

This puts it in the same effectiveness range as injectable GLP-1s for many patients provided the medication is taken correctly and consistently.

Orforglipron Weight Loss Data

In a major Phase 2 trial published in a top medical journal:

Average weight loss ranged from ~10% to nearly 15%
Achieved at just 36 weeks
46-75% of participants lost at least 10% of body weight

Longer Phase 3 trials are ongoing, but early results suggest orforglipron could match or exceed Wegovy pill long-term.

Verdict on Effectiveness

Short term (current data): roughly equal
Long term: orforglipron may have the edge

Side Effects and Tolerability

Wegovy Pill

Common side effects include:

Nausea
Diarrhoea
Constipation
Vomiting (especially during dose escalation)

Discontinuation due to side effects in tablet trials was approximately 7%, which is relatively low for GLP-1 medications.

Orforglipron

Side effects are similar and also mainly gastrointestinal.

However:

Discontinuation rates in early trials ranged from 10-17%
Higher doses caused more dropouts
Optimised dosing may reduce this in future trials

Verdict on Side Effects

Wegovy pill currently wins on tolerability based on available data however Orforglipron with dosing optimised maybe better.

Convenience and Daily Use (This Matters More Than People Think)

This is where the biggest difference lies.

Wegovy Pill Dosing Rules

To work properly, it must be taken:

On an empty stomach
With water only
No food, drink, or other medication for 30 minutes

For many people especially those with:

Shift work
Morning medications
Busy schedules

this becomes a major barrier to long-term adherence.

Orforglipron Dosing

Designed to be taken:

Once daily
With or without food
No waiting period

If final labels confirm this, orforglipron would be far easier to use consistently.

Verdict on Convenience

Orforglipron is clearly superior once approved.

UK Availability: What Can You Actually Get?

As of 2026:

Wegovy injection → available in the UK
Wegovy pill → under MHRA review
Orforglipron pill → awaiting UK/EU

If you are in London or elsewhere in England, your current legal options are limited to:

Injectable Wegovy (NHS or private)
Other approved injectable GLP-1s

The pill versions are not yet prescribable in the UK but when they are it will be accessible to buy Wegovy tablets or Orforglipron tablets oral forms from regulated Medcare Healthclinic & Pharmacy via Free Consultation.

So… Which Is Better?

Wegovy Pill Is Better If:

You want the most scientifically proven oral option
You value regulatory approval and established safety
You can manage strict daily dosing rules

Orforglipron Will Be Better If:

You want a true weight loss pill
Convenience and lifestyle fit matter most
You are willing to wait for UK approval

Final Verdict

Best choice today: Wegovy pill (on evidence and safety)

Best future option: Orforglipron pill (on convenience and potential)

In simple terms:

Wegovy pill is the safe, proven option
Orforglipron is the likely long-term winner

FAQs: Wegovy Pill vs Orforglipron Pill

Is there a weight loss pill available in the UK?

Not yet. Only injectable GLP-1 medications are currently authorised.

Is Wegovy pill the same as Ozempic?

It uses the same active drug (semaglutide) but at a different dose and for weight loss, not diabetes.

Will orforglipron replace injections?

Possibly if Phase 3 results confirm long-term safety and effectiveness.

Which pill causes fewer side effects?

Currently, Wegovy pill appears slightly better tolerated.

Can I lose 20% of my weight with these pills?

Some people may, but averages are closer to 10-15%.